Answers are grounded in this paper and cite their sources.
HIV-1 is the cause of AIDS, a destructive disease of the immune system. The ability of HIV-1 to induce selective apoptosis in certain CD4+ T lymphocytes, while establishing a persistent viral reservoir in a small population of CD4+ T cells, is a critical element for understanding the ability of HIV-1 to evade the immune system and designing new therapeutic approaches. Current therapies for HIV, such as HAART, promote resistant strains of the virus, and, therefore, there is a need for new therapeutic targets that will not develop resistance. As the plasma membrane plays an essential role in multiple steps in the HIV infection process, a thorough understanding of the membrane proteome is warranted. Proteomic studies have recently begun to identify potentially important cell-surface markers of HIV-1-infected cells. Elucidating the role of these plasma membrane proteins in HIV-1 infection may provide critically needed new therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Kehn‐Hall et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: